title: [A Patient with Stage IV Advanced Gastric Cancer with Multiple Liver Metastases Living for More Than 6 Years after Treatment with TS-1 Alone].
abstract: The patient was a 58-year-old man with advanced gastric cancer with multiple liver metastases. He received TXL/TS-1 therapy during February 2009, but treatment was stopped immediately when he developed anorexia, diarrhea, and numbness in his fingers. Therefore, only TS-1 was administered. Following treatment initiation, tumor marker levels promptly dropped. The gastric lesion disappeared and, to date, only a slight scar remains since April 2010. Similarly, liver metastases have not been detected since August 2011. There has been no lesion progression for 6 years since the start of the chemotherapy.
authors.affiliation: General Surgery, Shunan Memorial Hospital.
authors.forename: Ryosuke
authors.initials: R
authors.lastname: Hara
authors.forename: Kazuya
authors.initials: K
authors.lastname: Yoshida
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Fujii
authors.forename: Akihiko
authors.initials: A
authors.lastname: Ikeda
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Hashiyata
authors.forename: Kenbu
authors.initials: K
authors.lastname: Nakamoto
authors.forename: Motohiro
authors.initials: M
authors.lastname: Takeshige
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D004338:Drug Combinations; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010094:Oxonic Acid / Q000627:therapeutic use*; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D005641:Tegafur / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000964:Antimetabolites, Antineoplastic; D004338:Drug Combinations; C079198:S 1 (combination); D005641:Tegafur; D010094:Oxonic Acid